Preclinical Development of a Therapy for Chronic Traumatic Spinal Cord Injury in Rats Using Human Wharton's Jelly Mesenchymal Stromal Cells: Proof of Concept and Regulatory Compliance.

MLA

Vives, Joaquim, et al. “Preclinical Development of a Therapy for Chronic Traumatic Spinal Cord Injury in Rats Using Human Wharton’s Jelly Mesenchymal Stromal Cells: Proof of Concept and Regulatory Compliance.” Cells, vol. 11, no. 14, July 2022. EBSCOhost, https://doi.org/10.3390/cells11142153.

APA

Vives, J., Hernández, J., Mirabel, C., Puigdomenech-Poch, M., Romeo-Guitart, D., Marmolejo-Martínez-Artesero, S., Cabrera-Pérez, R., Jaramillo, J., Kumru, H., García-López, J., Vidal-Samsó, J., Navarro, X., & Coll-Bonet, R. (2022). Preclinical Development of a Therapy for Chronic Traumatic Spinal Cord Injury in Rats Using Human Wharton’s Jelly Mesenchymal Stromal Cells: Proof of Concept and Regulatory Compliance. Cells, 11(14). https://doi.org/10.3390/cells11142153

Chicago

Vives, Joaquim, Joaquim Hernández, Clémentine Mirabel, Maria Puigdomenech-Poch, David Romeo-Guitart, Sara Marmolejo-Martínez-Artesero, Raquel Cabrera-Pérez, et al. 2022. “Preclinical Development of a Therapy for Chronic Traumatic Spinal Cord Injury in Rats Using Human Wharton’s Jelly Mesenchymal Stromal Cells: Proof of Concept and Regulatory Compliance.” Cells 11 (14). doi:10.3390/cells11142153.